Japan seeks approval of fruquintinib for previously treated metastatic colorectal cancer

Colorectal cancer © Stock.adobe.com A new drug application (NDA) has been submitted to Japan’s Ministry of Health, Labor and Welfare seeking approval of fruquintinib (Elnato) for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC).1 The NDA is supported by data from the Phase 3 FRESCO-2 study (NCT04322539) and results from the […]